Time-Restricted Eating vs Traditional Dieting for Obesity

(NY-TREAT Trial)

Not currently recruiting at 1 trial location
MP
BL
DS
RB
Overseen ByRabiah Borhan, BS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores two different eating approaches to aid weight loss and improve metabolism in people with obesity. One group will follow time-restricted eating (TRE), consuming all meals within a 10-hour window each day. The other group will maintain their usual eating schedule, spread over 13 hours or more, known as Habitual Prolonged Eating Duration (HABIT). The researchers aim to determine if TRE can reduce the risk of heart problems compared to traditional eating patterns. Individuals aged 50 to 75 with obesity and conditions like prediabetes or diet-controlled type 2 diabetes may be suitable candidates.

As an unphased trial, this study provides a unique opportunity to contribute to understanding how different eating patterns can impact health and potentially improve quality of life.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it excludes those using medications that affect sleep, circadian rhythms, or metabolic function, so you may need to discuss your specific medications with the trial team.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that time-restricted eating (TRE) can aid in weight loss and improve insulin levels. This method involves eating only during a specific number of hours each day. Some studies have found that TRE can help individuals lose 3%–5% of their body weight within a few months. However, some participants might experience minor issues such as nausea, headaches, or changes in sleep patterns.

Overall, TRE appears to be well-tolerated, but individual responses can vary. Prospective participants should consult their doctor about any concerns before joining a study.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores two different approaches to eating schedules for addressing obesity. Traditional dieting often focuses on counting calories or specific food restrictions, but the TRE (Time-Restricted Eating) method is unique because it limits the time window for eating to 10 hours or less each day. This method might help regulate metabolism and improve weight management without requiring participants to change what they eat, just when they eat. The HABIT group, meanwhile, maintains a typical eating schedule, which allows researchers to compare the effects of time-restricted eating against a more conventional approach. This trial could reveal new insights into how timing, rather than just diet content, impacts obesity.

What evidence suggests that this trial's treatments could be effective for obesity?

This trial will compare Time-Restricted Eating (TRE) with a Habitual Prolonged Eating Duration (HABIT) approach. Studies have shown that TRE can aid in weight loss and improve health. Research indicates that individuals using TRE can lose about 3% to 5% of their body weight over a few months. TRE has also been linked to lower fasting insulin levels and enhanced fat burning. Participants in TRE programs often experience improvements in blood pressure and mood. These findings suggest that TRE might help reduce the risk of diseases like type 2 diabetes and heart disease by supporting weight loss and better metabolic health.13678

Who Is on the Research Team?

BL

Blandine Laferrère, M.D., Ph.D.

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for English-speaking adults aged 50-75 in the NYC area, with a BMI of 25-45 and conditions like hypertension, prediabetes or type 2 diabetes controlled by diet/metformin. Participants should have stable weight, eat breakfast habitually, and own a smartphone. Exclusions include smokers, those with severe diseases or sleep disorders, previous bariatric surgery patients, heavy alcohol consumers, and certain medication users.

Inclusion Criteria

In possession of a smart phone (iPhone or Android)
I have been diagnosed with dyslipidemia and am on a stable treatment plan.
I have prediabetes or Type 2 Diabetes managed with diet or metformin.
See 15 more

Exclusion Criteria

You have a history of serious eating or mental health problems.
I have a diagnosed sleep disorder or severe insomnia.
I do not have severe lung, kidney, or heart disease, and I am not currently ill.
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized to either a time restricted eating (TRE) window of 10 hours or a habitual eating window of 13 hours, with self-monitoring via a smartphone application

12 months
Ambulatory assessments at 0, 3, and 12 months

Follow-up

Participants are monitored for changes in body weight, fat mass, insulin resistance, and other metabolic markers

4 weeks
Final assessment at 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • HABIT
  • TRE
Trial Overview The study compares two eating patterns to improve heart health and metabolism in overweight individuals: Time Restricted Eating (TRE) where participants eat within a 10-hour window versus their usual pattern (HABIT) of eating over a span of about 13 hours daily. The focus is on whether TRE can better reduce cardiovascular risks.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: TRE GroupExperimental Treatment1 Intervention
Group II: HABIT GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

New York University

Collaborator

Trials
249
Recruited
229,000+

Salk Institute for Biological Studies

Collaborator

Trials
23
Recruited
2,200+

Published Research Related to This Trial

A time-restricted eating (TRE) intervention designed for people with type 2 diabetes and overweight includes a two-phase approach: an initial strict phase followed by a more flexible phase tailored to individual needs.
Support from healthcare professionals, family, and peers is crucial for maintaining motivation and adherence to the TRE regimen, emphasizing a whole-person approach that considers participants' past experiences.
Designing a Co-created Intervention to Promote Motivation and Maintenance of Time-Restricted Eating in Individuals With Overweight and Type 2 Diabetes.Hempler, NF., Bjerre, N., Varming, AR., et al.[2023]
In an 8-week pilot study involving 78 participants with obesity, those following a 14-hour time-restricted eating (TRE) schedule lost an average of 8.5% of their body weight, which was statistically significant compared to a 12-hour TRE group that lost 7.1%.
The 14:10 TRE group also experienced a significant reduction in fasting blood glucose levels by 7.6 mg/dl, indicating potential metabolic benefits, especially for those with elevated blood glucose at baseline.
Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trial.Peeke, PM., Greenway, FL., Billes, SK., et al.[2021]
In a study of 50 adults with overweight and obesity, participants successfully reduced their eating window from an average of 16 hours to about 12 hours over a 90-day time-restricted eating (TRE) intervention, leading to significant weight loss and reductions in waist circumference and blood pressure.
The TRE approach, which required no dietary counseling and was monitored through a smartphone app, showed a feasible and effective way to improve eating patterns and health outcomes in this population.
A Smartphone Intervention to Promote Time Restricted Eating Reduces Body Weight and Blood Pressure in Adults with Overweight and Obesity: A Pilot Study.Prasad, M., Fine, K., Gee, A., et al.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/35939311/
Effectiveness of Early Time-Restricted Eating for Weight Loss ...In this randomized clinical trial, eTRE was more effective for losing weight and improving diastolic blood pressure and mood than eating over a window of 12 or ...
Effects of time-restricted eating on body composition and ...TRE is effective in reducing body weight and lowering fasting insulin in overweight and obese women, without negatively affecting lean body mass ...
Time-restricted eating: Watching the clock to treat obesityIn participants with obesity, time-restricted eating results in 3%–5% weight loss over 2–12 months, versus controls. Reductions in body weight ...
Effectiveness of Early Time-Restricted Eating for Weight ...Adults who adhere to TRE typically lose 1% to 4% of their body weight within several weeks. Further, TRE increases fat oxidation and can improve ...
Time-restricted eating with calorie restriction on weight loss ...The pooled results showed that TRE with CR reduced the body weight, fat mass, and waist circumference significantly (WMD: −1.40, 95% CI: −1.81 ...
Time-restricted eating (TRE) for obesity in general practicePossible adverse effects of TRE are: nausea, vomiting, feeling unwell, diarrhea, constipation, headache, migraines, sleep disorders or changes ...
Intermittent Fasting and Obesity-Related Health OutcomesOutcomes associated with modified alternate-day fasting included a moderate reduction of body weight, body mass index, and cardiometabolic risk ...
The impact of intermittent fasting on body composition and ...Numerous studies have shown [18,19,20,21] that intermittent fasting can not only effectively reduce body weight but also improve metabolic ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security